|1.||Bäckström, Malin: 2 articles (08/2011 - 07/2011)|
|2.||Bergström, Tomas: 2 articles (08/2011 - 07/2011)|
|3.||Thomsson, Elisabeth: 2 articles (08/2011 - 07/2011)|
|4.||Grahn, Anna: 2 articles (08/2011 - 07/2011)|
|5.||Cohen, Jeffrey I: 2 articles (04/2009 - 11/2002)|
|6.||Lee, Jay: 2 articles (01/2003 - 12/2002)|
|7.||Arvin, Ann M: 2 articles (01/2003 - 12/2002)|
|8.||Mo, Chengjun: 2 articles (01/2003 - 12/2002)|
|9.||Grose, Charles: 2 articles (12/2002 - 11/2002)|
|10.||Ritchie, Alanna: 1 article (01/2013)|
11/01/1998 - "Thus, this detailed study of VZV gE cellular trafficking has revealed potential roles for gE during viral infection."
08/01/2011 - "We therefore propose that VZV gE can be used for serological discrimination of CNS infections caused by VZV and HSV-1."
04/10/2009 - "Expression of VZV gE on the surface of cells did not interfere with VZV infection. "
11/01/2002 - "Taken together, the results showed that phosphorylation of VZV gE by ORF47 or CKII determined whether VZV infection proceeded toward a pathway likely involved with either virion production or cell-cell spread."
09/01/1997 - "The purpose of this study was to compare the antibody responses to varicella-zoster virus (VZV) gE and gB after natural VZV infection and after vaccination with live attenuated OKA vaccine in order to determine the relative importance of these proteins as components of a subunit vaccine. "
|2.||Melanoma (Melanoma, Malignant)
07/01/2011 - "When compared to a conventional whole virus antigen, the VZV gE showed similar results in ELISA-based seroprevalence studies of 854 samples derived from blood donors, students, ischemic stroke patients and their controls, including samples with border-line results in previous analyses. "
|5.||Contagious Ecthyma (Orf)
|1.||Proteins (Proteins, Gene)
|3.||Immunoglobulin G (IgG)